Related Experiment Videos
Chondrosarcoma of the head and neck
B B Burkey1, H T Hoffman, S R Baker
1Department of Otolaryngology-Head and Neck Surgery, University of Michigan Hospitals, Ann Arbor.
The Laryngoscope
|December 1, 1990
Summary
Surgical resection is key for treating head and neck chondrosarcoma, a rare cancer. This approach offers a 70% survival rate, emphasizing the importance of aggressive or conservative surgery for long-term patient outcomes.
Area of Science:
- Oncology
- Head and Neck Surgery
- Pathology
Background:
- Chondrosarcoma is an uncommon malignancy affecting the head and neck region.
- Limited data exists on the specific characteristics and treatment response of head and neck chondrosarcomas.
Purpose of the Study:
- To define the characteristics of chondrosarcoma in the head and neck.
- To evaluate the treatment response and survival outcomes for head and neck chondrosarcoma.
Main Methods:
- Retrospective study of 14 chondrosarcoma cases treated at the University of Michigan over 25 years.
- Review of tumors originating in the nose, paranasal sinuses, mandible, temporal bone, and larynx.
- Analysis of treatment modalities, focusing on surgical resection, and patient survival rates.
Main Results:
- Aggressive surgical resection was the primary treatment modality.
- Overall survival rate was 70% with an average follow-up of 3.5 years.
- Survival rates varied by anatomical site: highest for temporal bone lesions, lowest for paranasal sinus lesions.
- Non-surgical modalities did not cure unresectable lesions.
Conclusions:
- Wide surgical resection remains the cornerstone of effective treatment for head and neck chondrosarcoma.
- Conservative surgical approaches can achieve long-term survival when necessary for preserving critical structures.
- Surgical intervention is crucial, as other modalities are ineffective for unresectable cases.